Targeting NF-κB and induction of apoptosis by novel NF-κB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells

被引：15

作者：

Kimura, Noriko

Miyakawa, Yoshitaka ^{[1
]}

Kohmura, Kanoko

Umezawa, Kazuo

Ikeda, Yasuo

Kizaki, Masahiro

机构：

[1] Keio Univ, Sch Med, Dept Internal Med, Div Hematol, Tokyo 1608582, Japan

[2] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kanagawa, Japan

来源：

LEUKEMIA RESEARCH | 2007年 / 31卷 / 11期

关键词：

NF-kappa B; Burkitt lymphoma; apoptosis; caspase-3; IAP;

D O I：

10.1016/j.leukres.2007.02.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A new NF-kappa B inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), inhibited proliferation and induced apoptosis in human Burkitt lymphoma, HS-Sultan and Daudi cell lines. The activation of caspase-3 and the cleavage of caspase substrate PARP were observed after treatment with DHMEQ. The induction of apoptosis by DHMEQ was prevented by the pretreatment of Burkitt lymphoma cells with pan-caspase inhibitor, z-VAD-FMK. The expression of anti-apoptotic factors such as IAP-1 and XIAP was suppressed by DHMEQ. Phosphorylation of ERK and INK was induced by DHMEQ. In conclusion, these results demonstrate that NF-kappa B might be an ideal target to develop for new anti-cancer drugs for Burkitt lymphoma. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：1529 / 1535

页数：7

共 50 条

[1] Targeting NF-κB and induction of apoptosis by dehydroxymethylepoxyquinomicin (DHMEQ) in multiple myeloma cells.
Miyakawa, Y
Kohmura, K
Saito, K
Yoshida, H
Ikejima, A
Hattori, Y
Ohnishi, Y
Nakamura, M
Ikeda, Y
Umezawa, K
Kizaki, M
BLOOD, 2004, 104 (11) : 926A - 926A
[2] Growth suppression and apoptosis induction in synovial sarcoma cell lines by a novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ)
Horiuchi, Keisuke
Morioka, Hideo
Nishimoto, Kazumasa
Suzuki, Yoshihisa
Susa, Michiro
Nakayama, Robert
Kawai, Akira
Sonobe, Hiroshi
Takaishi, Hironari
Ozaki, Toshifumi
Yabe, Hiroo
Umezawa, Kazuo
Toyama, Yoshiaki
CANCER LETTERS, 2008, 272 (02) : 336 - 344
[3] Induction of immunosuppressive dendritic cells by a novel NF-κB inhibitor, DHMEQ
Aoyagi, Takeshi
Yamashita, Kenichiro
Yanagawa, Yoshiki
Goto, Ryoichi
Igarashi, Rumi
Haga, Sanae
Ozaki, Michitaka
Onoe, Kazunori
Umezawa, Kazuo
Furukawa, Hiroyuki
Todo, Satoru
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 483 - 483
[4] Efficient Cellular Uptake of the Novel NF-κB Inhibitor (-)-DHMEQ and Irreversible Inhibition of NF-κB in Neoplastic Cells
Shimada, Chika
Ninomiya, Yoko
Suzuki, Eriko
Umezawa, Kazuo
ONCOLOGY RESEARCH, 2010, 18 (11-12) : 529 - 535
[5] A novel NF-κB inhibitor DHMEQ selectively targets constitutive NF-κB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo
Watanabe, M
Dewan, Z
Okamura, T
Sasaki, M
Itoh, K
Higashihara, M
Mizoguchi, H
Honda, M
Sata, T
Watanabe, T
Yamamoto, N
Umezawa, K
Horie, R
INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (01) : 32 - 38
[6] Induction of histidine decarboxylase in macrophages inhibited by the novel NF-κB inhibitor (-)-DHMEQ
Suzuki, Eriko
Ninomiya, Yoko
Umezawa, Kazuo
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 379 (02) : 379 - 383
[7] A small molecule inhibitor of NF-κB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells
Wong, Jason Ho Ting
Lui, Vivian Wai Yan
Umezawa, Kazuo
Ho, Yeung
Wong, Elaine Yue Ling
Ng, Margaret Heung Ling
Cheng, Suk Hang
Tsang, Chi Man
Tsao, Sai Wah
Chan, Anthony Tak Cheung
CANCER LETTERS, 2010, 287 (01) : 23 - 32
[8] Induction of apoptosis with I-κB, the inhibitor of NF-κB
Paillard, F
HUMAN GENE THERAPY, 1999, 10 (01) : 1 - 3
[9] Inhibition of macrophage activation and phagocytosis by a novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin
Suzuki, E.
Umezawa, K.
BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (09) : 578 - 586
[10] Anticancer Activity of Novel NF-κB Inhibitor DHMEQ by Intraperitoneal Administration
Umezawa, Kazuo
Breborowicz, Andrzej
Gantsev, Shamil
ONCOLOGY RESEARCH, 2020, 28 (05) : 541 - 550

← 1 2 3 4 5 →